Eisai and Biogen announced that Eisai has initiated a rolling submission to the US Food and Drug Administration (FDA) of a Biologics License Application (BLA) for lecanemab (BAN2401), the company’s investigational anti-amyloid beta (Aß) protofibril antibody, for the treatment of early Alzheimer’s disease (early AD).

While she on her way to Allegiant Stadium, just a few blocks away, she stopped to save a man’s life.

No one spends more time on the road than truck drivers. That’s why the Nevada Highway Patrol is now leading a campaign to raise awareness of human trafficking by educating commercial truck drivers on identifying signs of trafficking.

Tuesday is National Voter Registration Day.

The drive-thru COVID-19 test and vaccination site at UNLV is moving locations this week, officials announced.

A new self-exclusion program, PlayPause from Conscious Gaming, would create a cross-jurisdictional database to keep gamblers who can’t play in one place from jumping to another.

There may be a light at the end of the tunnel.

In a welcome change of behavior and social progress, individuals are now more willing to promote mental health in the same way that physical health has long been prioritized.

Millions of Americans have traded traditional work wardrobes for loungewear in the nearly two years of working remotely during the pandemic.